Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Hematologic Neoplasms 2Pancreatic Neoplasms 1Pain, Postoperative 1Pain, Intractable 1Neoplasms 1Neoplasm Metastasis 1Mucositis 1Malignant Female Reproductive System Neoplasm 1Liver Neoplasms 1Leukemia 1Kidney Neoplasms 1Duodenal Neoplasms 1Digestive System Diseases 1Carcinoma, Hepatocellular 1Bone Marrow Failure Disorders 1Anemia, Aplastic 1Agnosia 1

Interventions

Pancreaticojejunostomy 2obeticholic acid 1fludarabine 1aldesleukin 1X-Rays 1Tissue Adhesives 1Tea 1Stents 1Specimen Handling 1Phantoms, Imaging 1Octreotide 1Iopamidol 1Hydromorphone 1Hydrocortisone 1High-Energy Shock Waves 1Endoscopy, Gastrointestinal 1Endoscopic Mucosal Resection 1Cyclophosphamide 1Bupivacaine 1Biopsy 1Anti-Bacterial Agents 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Duodenal Neoplasms × Hydromorphone × 1 year × Clear all
NCT06411795 2026-02-03

Rectus Sheath Block With Liposomal Bupivacaine Versus Thoracic Epidural Analgesia for Pain Control Following Pancreatoduodenectomy

Masonic Cancer Center, University of Minnesota

Phase 2 Recruiting
78 enrolled
Gastrointestinal

Duodenal Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡